Inari Medical NARI
$ 55.54
2.07%
Quarterly report 2024-Q3
added 10-28-2024
Inari Medical Balance Sheet 2011-2024 | NARI
Annual Balance Sheet Inari Medical
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-27.9 M | -63.5 M | - | -4.16 M | -12 M | - | - | - | - | - | - | - |
Long Term Debt |
31 M | 28.4 M | - | 19.5 M | 9.84 M | - | - | - | - | - | - | - |
Long Term Debt Current |
1.31 M | 802 K | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 74.8 M | 64.2 M | - | - | - | - | - | - | - |
Total Current Liabilities |
56.2 M | 42.5 M | 13.8 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
87.2 M | 72.3 M | 13.8 M | 83.7 M | 66.3 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-46.8 M | -17.6 M | -27.4 M | -41.2 M | -40.1 M | - | - | - | - | - | - | - |
Total Assets |
504 M | 312 M | 214 M | 44.5 M | 26.9 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
60.2 M | 92.8 M | 115 M | 24 M | 21.9 M | - | - | - | - | - | - | - |
Book Value |
417 M | 239 M | 200 M | -39.1 M | -39.4 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
417 M | 239 M | 200 M | -39.1 M | -39.4 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Inari Medical
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
31.1 M | 31.2 M | 29.8 M | 30.4 M | 30.6 M | 31.1 M | 31.5 M | 31 M | 30.4 M | - | 28.3 M | 28.4 M | 28.5 M | 156 K | 351 K | - | - | 29.6 M | - | 19.5 M | 19.5 M | 19.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
262 M | 249 M | 215 M | 209 M | 96.7 M | 89.3 M | 79.8 M | 87.2 M | 72.7 M | - | 65.3 M | 72.3 M | 58.1 M | 31.7 M | 21 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 29.5 M | 29.5 M | 29.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-122 M | -104 M | -72.7 M | -48.5 M | -43.8 M | -47 M | -49.1 M | -46.8 M | -41.1 M | - | -20.7 M | -17.6 M | -18.7 M | -15.9 M | -20 M | -27.4 M | -27.4 M | -27.4 M | -27.4 M | -41.2 M | -41.2 M | -41.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
697 M | 673 M | 662 M | 674 M | 549 M | 525 M | 507 M | 504 M | 488 M | - | 484 M | 312 M | 292 M | 254 M | 235 M | 214 M | 214 M | 214 M | 214 M | 44.5 M | 44.5 M | 44.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
41.1 M | 70.1 M | 66.7 M | 38.6 M | 89.2 M | 57.8 M | 56.6 M | 60.2 M | 83.5 M | 79.7 M | 187 M | 92.8 M | 81.2 M | 91.3 M | 103 M | 114 M | 114 M | 114 M | 114 M | 23.6 M | 23.6 M | 23.6 M | - | 21.9 M | - | - | - | 6.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
435 M | 424 M | 447 M | 465 M | 452 M | 436 M | 427 M | 417 M | 415 M | - | 419 M | 239 M | 234 M | 222 M | 214 M | 200 M | 200 M | 200 M | 200 M | 15 M | 15 M | 15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
435 M | 424 M | 447 M | 465 M | 452 M | 436 M | 427 M | 417 M | 415 M | 414 M | 419 M | 239 M | 234 M | 222 M | 214 M | 200 M | 200 M | 200 M | 200 M | -39.1 M | -39.1 M | -39.1 M | -40.2 M | -39.4 M | - | - | - | -29.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency